We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| (MM) | NASDAQ:IDIX | NASDAQ | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 24.50 | 0.00 | 01:00:00 |
From Jul 2019 to Jul 2024
"Vertex: FDA Puts Partial Hold on Study of Hepatitis C Drug," at 6:07 p.m. ET, mistakenly implied in the fourth paragraph that no serious adverse events or safety issues were reported in studies of the drug at any dose. It should have specified that in patients who were given 100-milligram or 200-milligram doses of the drug in the European study, no serious adverse events or liver or cardiac safety issues were reported.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year (MM) Chart |
1 Month (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
